Triplex real-time pcr melting curve analysis for detecting mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 5, 2013, Pages 1097-1103

  Liu, Qingyun ^a   Luo, Tao ^a   Li, Jing ^b   Mei, Jian ^b   Gao, Qian ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Drug resistance; M. tuberculosis; Rapid diagnosis; TB

Indexed keywords

AMIKACIN; CAPREOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; EIS PROTEIN; KANAMYCIN; MEMBRANE PROTEIN; OFLOXACIN; QUINOLONE DERIVATIVE; RRS PROTEIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VALIDATION PROCESS; WILD TYPE;

ANTITUBERCULAR AGENTS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE PROBES; POINT MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; TRANSITION TEMPERATURE;

EID: 84877108004     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks509     Document Type: Article

References (34)

1. Dye C, Williams BG, Espinal MA et al. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 2002; 295: 2042-6.
2. Stokstad E. Infectious disease. Drug-resistant TB on the rise. Science 2000; 287: 2391.
3. Perdigao J, Macedo R, Silva C et al. From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition. J Antimicrob Chemother 2013; 68: 27-33.
4. Gelmanova IY, Keshavjee S, Golubchikova VT et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007; 85: 703-11.
5. Wells CD, Cegielski JP, Nelson LJ et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196 Suppl 1: S86-107.
6. Zhao Y, Xu S, Wang L et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161-70.
7. Takiff HE, Salazar L, Guerrero C et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994; 38: 773-80.
8. Alangaden GJ, Kreiswirth BN, Aouad A et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998; 42: 1295-7.
9. Suzuki Y, Katsukawa C, Tamaru A et al. Detection of kanamycinresistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 1998; 36: 1220-5.
10. Maus CE, Plikaytis BB, Shinnick TM. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49: 571-7.
11. Zaunbrecher MA, Sikes RD Jr, Metchock B et al. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2009; 106: 20004-9.
12. Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 2003; 3: 432-42.
13. Boehme CC, Nicol MP, Nabeta P et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-505.
14. Chen X, Kong F, Wang Q et al. Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis. J Clin Microbiol 2011; 49: 3450-7.
15. Hillemann D, Rusch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2009; 47: 1767-2.
16. Bravo LT, Tuohy MJ, Ang C et al. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. J Clin Microbiol 2009; 47: 3985-0.
17. Huang WL, Chi TL, Wu MH et al. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2011; 49: 2502-8.
18. Luo T, Jiang L, Sun W,et al. Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis. J Clin Microbiol 2011; 49: 3132-8.
19. Del Sal G, Manfioletti G, Schneider C. The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing. Biotechniques 1989; 7: 514-20.
20. Pont-Kingdon G, Lyon E. Direct molecular haplotyping by melting curve analysis of hybridization probes: beta 2-adrenergic receptor haplotypes as an example. Nucleic Acids Res 2005; 33: e89.
21. Johnson R, Streicher EM, Louw GE et al. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol 2006; 8: 97-111.
22. Moreira BG, You Y, Behlke MA et al. Effects of fluorescent dyes, quenchers, and dangling ends on DNA duplex stability. Biochem Biophys Res Commun 2005; 327: 473-84.
23. Gandhi NR, Nunn P, Dheda K et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-43.
24. Lee AS, Ong DC, Wong JC et al. High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis. PLoS One 2012; 7: e31934.
25. Von Groll A, Martin A, Jureen P et al. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother 2009; 53: 4498-500.
26. Maruri F, Sterling TR, Kaiga AW et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 2012; 67: 819-31.
27. Mokrousov I, Otten T, Manicheva O et al. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother 2008; 52: 2937-9.
28. Chakravorty S, Aladegbami B, Thoms K et al. Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay. J ClinMicrobiol 2011; 49: 932-40.
29. Zhang X, Zhao B, Liu L et al. Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China. J Clin Microbiol 2012; 50: 1471-4.
30. Georghiou SB, Magana M, Garfein RS et al. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 2012; 7: e33275.
31. Engstrom A, Perskvist N, Werngren J et al. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2011; 66: 1247-54.
32. Engstrom A, Morcillo N, Imperiale B et al. Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. J Clin Microbiol 2012; 50: 2026-33.
33. Gikalo MB, Nosova EY, Krylova LY et al. The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region. J Antimicrob Chemother 2012; 67: 2107-9.
34. Blakemore R, Story E, Helb D et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010; 48: 2495-501.